CRL Offers Clients Global Services Integrated Structure
Clinical Reference Laboratory Inc, (Kansas, USA) (‘CRL Global Services’), an independent clinical testing laboratory operation, now offers its clients an integrated and optimized infrastructure to support their global clinical trials following the establishment of an additional laboratory in Cambridgeshire, United Kingdom, late in 2009.
CRL Global Services brings together a network of clinical laboratories around the world to provide global logistics, consistent instrumentation, standardized laboratory safety-, and centralized biomarker testing. CRL Global Services’ integrated system supports early to late phase pharmaceutical drug development. CRL Global Services has European operations in the UK and a worldwide technology platform.
For the client, CRL Global Services’ system provides centralized global project set-up and management, centralized data management, reporting, and financial tracking. CRL Global Services also provides web-based project information tools – Web-OASIS™ for investigators, and Trials-OASIS™ for sponsors.
Behind the Buzz: Why Clinical Research Leaders Flock to SCOPE Summit
February 7th 2025In this episode, we meet with Micah Lieberman, Executive Conference Director for SCOPE Summit (Summit for Clinical Ops Executives) at Cambridge Innovation Institute. We will dive deep into the critical role of collaboration within the clinical research ecosystem. How do we bring together diverse stakeholders—sponsors, CROs, clinical trial tech innovators, suppliers, patients, sites, advocacy organizations, investors, and non-profits—to share best practices in trial design, program planning, innovation, and clinical operations? We’ll explore why it’s vital for thought leaders to step beyond their own organizations and learn from others, exchanging ideas that drive advancements in clinical research. Additionally, we’ll discuss the pivotal role of scientific conferences like SCOPE Summit in fostering these essential connections and collaborations, helping shape the future of clinical trials. Join us as we uncover how collective wisdom and cross-industry partnerships are transforming the landscape of clinical research.
Reaching Diverse Patient Populations With Personalized Treatment Methods
January 20th 2025Daejin Abidoye, head of solid tumors, oncology development, AbbVie, discusses a number of topics around diversity in clinical research including industry’s greatest challenges in reaching diverse patient populations, personalized treatment methods, recruitment strategies, and more.
POETYK PsA-2 Trial Shows Efficacy of Sotyktu as an Oral Therapy for Psoriatic Arthritis
March 11th 2025Sotyktu (deucravacitinib) demonstrated significant efficacy in improving psoriatic arthritis symptoms compared to placebo in the Phase III POETYK PsA-2 trial, with a well-tolerated safety profile.
